Profile
Adolf Hoess is currently the Chief Executive Officer at Affimed GmbH and SomaServe Ltd. He is also the Chairman-Management Board at Affimed NV Niederlassung Deutschland.
Previously, he held the position of Chief Executive Officer & Director at Affimed NV from 2010 to 2024.
He was also the Chief Executive Officer at Jenowis AG and Director at Amphivena Therapeutics, Inc. Dr. Hoess has a background in academia, having worked as a Principal at Harvard University in 1993.
He also served as the Vice President-Licensing & Business Development at MorphoSys AG and General Manager & VP-Molecular Division at Carl Zeiss Jena GmbH.
Additionally, he held the position of Chief Commercial Officer at Shire Orphan Therapies GmbH.
Dr. Hoess obtained his doctorate degrees from Technische Universität München in 1997 and Ludwig-Maximilians-Universität München in 1991.
Adolf Hoess active positions
| Companies | Position | Start |
|---|---|---|
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Chief Executive Officer | - |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Chief Executive Officer | 01/09/2011 |
SomaServe Ltd.
SomaServe Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Chief Executive Officer | 01/10/2024 |
Former positions of Adolf Hoess
| Companies | Position | End |
|---|---|---|
| AFFIMED N.V. | Chief Executive Officer | 15/01/2024 |
Carl Zeiss Jena GmbH
Carl Zeiss Jena GmbH Medical SpecialtiesHealth Technology Manufactures lenses for health care, photography, projecting and research services | Corporate Officer/Principal | 01/01/2002 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1993 |
Jenowis AG | Chief Executive Officer | - |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Director/Board Member | - |
Education of Adolf Hoess
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Affimed NV
Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Carl Zeiss Jena GmbH
Carl Zeiss Jena GmbH Medical SpecialtiesHealth Technology Manufactures lenses for health care, photography, projecting and research services | Health Technology |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Health Technology |
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Health Technology |
Jenowis AG | |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
SomaServe Ltd.
SomaServe Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
- Stock Market
- Insiders
- Adolf Hoess
















